rss
Arch Dis Child Fetal Neonatal Ed 2008;93:F198-F200 doi:10.1136/adc.2007.121962
  • Original article

Systemic antifungal prophylaxis for very low birthweight infants: a systematic review

  1. L Clerihew1,2,3,
  2. N Austin1,2,3,
  3. W McGuire1,2,3
  1. 1
    Ninewells Hospital and Medical School, Dundee, Scotland
  2. 2
    Christchurch Women’s Hospital, Christchurch, New Zealand
  3. 3
    Australian National University, Canberra, Australia
  1. W McGuire, Canberra Hospital, ACT 2606, Australia; william.mcguire{at}act.gov.au
  • Accepted 8 August 2007
  • Published Online First 3 September 2007

Abstract

Systematic review and meta-analysis of four randomised controlled trials suggest that prophylactic fluconazole reduces the incidence of invasive fungal infection in very low birthweight infants. Further trials are needed to provide more precise estimates of effect size, and to assess the effect on mortality, neurodevelopment and the emergence of antifungal resistance.

Footnotes

  • Competing interests: WMcG has received research funds from Pfizer UK Ltd, a manufacturer of fluconazole. This company had no role in the collection, analysis and interpretation of data, or in the writing of the report or decision to submit for publication.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. adc.2007.121962v1
    2. 93/3/F198 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.